MetaADEDB 2.0 @ LMMD
Oseltamivir
(PGZUMBJQJWIWGJ-ONAKXNSWSA-N)
Structure
SMILES
OP(=O)(O)O.CCOC(=O)C1=C[C@H]([C@@H]([C@H](C1)N)NC(=O)C)OC(CC)CC
Molecular Formula:
C16H31N2O8P
Molecular Weight:
410.400
Log P:
1.4480
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
5
TPSA:
178.22
CAS Number(s):
204255-11-8
Synonym(s)
1.
Oseltamivir
2.
GS 4071
3.
GS 4104
4.
GS-4071
5.
GS-4104
6.
GS4071
7.
GS4104
8.
Tamiflu
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1VomitingFAERS: 918
Canada Vigilance: 38
Canada Vigilance
US FAERS
2No adverse eventFAERS: 812US FAERS
3Drug exposure during pregnancyFAERS: 668US FAERS
4NauseaFAERS: 443
Canada Vigilance: 21
Canada Vigilance
US FAERS
5PregnancyFAERS: 365US FAERS
6OverdoseFAERS: 265
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Drug ineffectiveFAERS: 253
Canada Vigilance: 11
Canada Vigilance
US FAERS
8DeliriumFAERS: 200
Canada Vigilance: 8
Canada Vigilance
US FAERS
9MalaiseFAERS: 193
Canada Vigilance: 2
Canada Vigilance
US FAERS
10PneumoniaFAERS: 192
Canada Vigilance: 1
Canada Vigilance
US FAERS
11HeadacheFAERS: 187
Canada Vigilance: 12
Canada Vigilance
US FAERS
12InfluenzaFAERS: 185US FAERS
13DizzinessFAERS: 177
Canada Vigilance: 15
Canada Vigilance
US FAERS
14Accidental overdoseFAERS: 121
Canada Vigilance: 1
Canada Vigilance
US FAERS
15Feeling abnormalFAERS: 119
Canada Vigilance: 2
Canada Vigilance
US FAERS
16AnxietyFAERS: 117US FAERS
17Incorrect dose administeredFAERS: 116US FAERS
18UrticariaFAERS: 112
Canada Vigilance: 8
Canada Vigilance
US FAERS
19Medication ErrorFAERS: 95US FAERS
20Abdominal PainFAERS: 92
Canada Vigilance: 5
Canada Vigilance
US FAERS
21CryingFAERS: 90
Canada Vigilance: 2
Canada Vigilance
US FAERS
22HypersensitivityFAERS: 87
Canada Vigilance: 3
Canada Vigilance
US FAERS
23Maternal exposure during pregnancyFAERS: 86
Canada Vigilance: 1
Canada Vigilance
US FAERS
24AgitationFAERS: 82
Canada Vigilance: 2
Canada Vigilance
US FAERS
25PainFAERS: 82
Canada Vigilance: 3
Canada Vigilance
US FAERS
26PruritusFAERS: 81
Canada Vigilance: 9
Canada Vigilance
US FAERS
27FatigueFAERS: 77
Canada Vigilance: 5
Canada Vigilance
US FAERS
28ScreamingFAERS: 77
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Respiratory FailureFAERS: 76
Canada Vigilance: 1
Canada Vigilance
US FAERS
30TremorFAERS: 72
Canada Vigilance: 7
Canada Vigilance
US FAERS
31Depressed Level of ConsciousnessFAERS: 71US FAERS
32DisorientationFAERS: 70
Canada Vigilance: 2
Canada Vigilance
US FAERS
33Product quality issueFAERS: 68US FAERS
34DysgeusiaFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Disease ProgressionFAERS: 54US FAERS
36Abdominal discomfortFAERS: 53
Canada Vigilance: 7
Canada Vigilance
US FAERS
37AstheniaFAERS: 53US FAERS
38Drug administration errorFAERS: 50US FAERS
39PalpitationsFAERS: 50
Canada Vigilance: 4
Canada Vigilance
US FAERS
40DehydrationFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
41RestlessnessFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Chest PainFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
43Pathogen resistanceFAERS: 47
Canada Vigilance: 6
Canada Vigilance
US FAERS
44SomnolenceFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
45AmnesiaFAERS: 44
Canada Vigilance: 2
Canada Vigilance
US FAERS
46AngerFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
47Visual ImpairmentFAERS: 39
Canada Vigilance: 2
Canada Vigilance
US FAERS
48ErythemaFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
49Completed SuicideFAERS: 37US FAERS
50Lip swellingFAERS: 37US FAERS
51Memory impairmentFAERS: 37US FAERS
52RetchingFAERS: 37US FAERS
53VertigoFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
54EpistaxisFAERS: 36
Canada Vigilance: 3
Canada Vigilance
US FAERS
55Oropharyngeal painFAERS: 35US FAERS
56Suicide attemptFAERS: 35US FAERS
57Altered state of consciousnessFAERS: 34US FAERS
58Chest discomfortFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
59Septic ShockFAERS: 32US FAERS
60Weight decreasedFAERS: 31US FAERS
61RhabdomyolysisFAERS: 28US FAERS
62SepsisFAERS: 27US FAERS
63White blood cell count decreasedFAERS: 27US FAERS
64Cardiac ArrestFAERS: 26US FAERS
65ParanoiaFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
66ChillsFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
67MyalgiaFAERS: 25US FAERS
68Blood creatine phosphokinase increasedFAERS: 24US FAERS
69Sudden deathFAERS: 24US FAERS
70SyncopeFAERS: 24US FAERS
71Unevaluable eventFAERS: 24US FAERS
72ArthralgiaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Stevens-Johnson SyndromeFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
74ThrombocytopeniaFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
75LethargyFAERS: 22US FAERS
76Personality ChangeFAERS: 22US FAERS
77Rash erythematousFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
78ShockFAERS: 21US FAERS
79StomatitisFAERS: 21US FAERS
80jaundiceFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
81Back PainFAERS: 20US FAERS
82Drug resistanceFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
83General physical health deteriorationFAERS: 20US FAERS
84NervousnessFAERS: 20US FAERS
85AgeusiaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
86BlindnessFAERS: 19US FAERS
87Middle insomniaFAERS: 19US FAERS
88ChromaturiaFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
89DyspepsiaFAERS: 18US FAERS
90EncephalitisFAERS: 18US FAERS
91Expired drug administeredFAERS: 18US FAERS
92TachycardiaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
93AnosmiaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
94DiplopiaFAERS: 17US FAERS
95DysarthriaFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
96FlatulenceFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Live BirthFAERS: 17US FAERS
98Psychiatric symptomFAERS: 17US FAERS
99SwellingFAERS: 17US FAERS
100Drug dose omissionFAERS: 16US FAERS
101Emotional disorderFAERS: 16US FAERS
102Emotional distressFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
103HypoxiaFAERS: 16US FAERS
104MyocarditisFAERS: 16US FAERS
105StaringFAERS: 16US FAERS
106Alanine Aminotransferase IncreasedFAERS: 15US FAERS
107Hallucinations, mixedFAERS: 15US FAERS
108PancytopeniaFAERS: 15US FAERS
109StillbirthFAERS: 15US FAERS
110AbasiaFAERS: 14US FAERS
111AphasiaFAERS: 14US FAERS
112Circumstance or information capable of leading to medication errorFAERS: 14US FAERS
113Depressed moodFAERS: 14US FAERS
114DiscomfortFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Drug dispensing errorFAERS: 14US FAERS
116HepatitisFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
117HypersomniaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
118IncoherentFAERS: 14US FAERS
119InfectionFAERS: 14US FAERS
120LeukopeniaFAERS: 14US FAERS
121Maternal exposure timing unspecifiedFAERS: 14US FAERS
122Product taste abnormalFAERS: 14US FAERS
123TinnitusFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
124AlopeciaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Cerebrovascular accidentFAERS: 13US FAERS
126EpilepsyFAERS: 13US FAERS
127Intentional self-injuryFAERS: 13US FAERS
128Mood swingsFAERS: 13US FAERS
129Musculoskeletal stiffnessFAERS: 13US FAERS
130Aspartate Aminotransferase IncreasedFAERS: 12US FAERS
131Disseminated Intravascular CoagulationFAERS: 12US FAERS
132DysphoniaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
133HypotensionFAERS: 12US FAERS
134Mental status changesFAERS: 12US FAERS
135PancreatitisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
136Toxic Epidermal NecrolysisFAERS: 12US FAERS
137Wrong technique in drug usage processFAERS: 12US FAERS
138Cold sweatFAERS: 11US FAERS
139Drug prescribing errorFAERS: 11US FAERS
140Expired product administeredFAERS: 11US FAERS
141Eye painFAERS: 11US FAERS
142Inappropriate schedule of drug administrationFAERS: 11US FAERS
143NasopharyngitisFAERS: 11US FAERS
144PallorFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
145Poor quality sleepFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Respiratory arrestFAERS: 11US FAERS
147SomnambulismFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
148Unresponsive to stimuliFAERS: 11US FAERS
149Visual disturbanceFAERS: 11US FAERS
150Acute respiratory failureFAERS: 10US FAERS
151AsthmaFAERS: 10US FAERS
152Blood glucose increasedFAERS: 10US FAERS
153Burning sensationFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
154Drug exposure via breast milkFAERS: 10US FAERS
155Erythema MultiformeFAERS: 10US FAERS
156Feeling ColdFAERS: 10US FAERS
157MeningitisFAERS: 10US FAERS
158MetrorrhagiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
159MyoclonusFAERS: 10US FAERS
160Acute kidney injuryFAERS: 9US FAERS
161Anaphylactic shockFAERS: 9US FAERS
162Extra dose administeredFAERS: 9US FAERS
163Eye InfectionFAERS: 9US FAERS
164Feeling jitteryFAERS: 9US FAERS
165HypophagiaFAERS: 9US FAERS
166Impaired work abilityFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Intentional product misuseFAERS: 9US FAERS
168Intercepted product storage errorFAERS: 9US FAERS
169Nephrotic SyndromeFAERS: 9US FAERS
170Night sweatsFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
171Peripheral swellingFAERS: 9US FAERS
172Productive CoughFAERS: 9US FAERS
173Status EpilepticusFAERS: 9US FAERS
174StrabismusFAERS: 9US FAERS
175Blood alkaline phosphatase increasedFAERS: 8US FAERS
176EructationFAERS: 8US FAERS
177ExcitabilityFAERS: 8US FAERS
178Myocardial InfarctionFAERS: 8US FAERS
179PneumothoraxFAERS: 8US FAERS
180Sleep TalkingFAERS: 8US FAERS
181Throat irritationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
182WheezingFAERS: 8US FAERS
183Atrial FibrillationFAERS: 7US FAERS
184Blood creatinine increasedFAERS: 7US FAERS
185Blood lactate dehydrogenase increasedFAERS: 7US FAERS
186BradycardiaFAERS: 7US FAERS
187Brain DeathFAERS: 7US FAERS
188CholestasisFAERS: 7US FAERS
189ConstipationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
190DeafnessFAERS: 7US FAERS
191EczemaFAERS: 7US FAERS
192Exposure during breast feedingFAERS: 7US FAERS
193FlushingFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
194Head BangingFAERS: 7US FAERS
195HyperventilationFAERS: 7US FAERS
196InflammationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
197Intercepted medication errorFAERS: 7US FAERS
198Muscle tightnessFAERS: 7US FAERS
199NeutropeniaFAERS: 7US FAERS
200Product prescribing errorFAERS: 7US FAERS
201Product storage errorFAERS: 7US FAERS
202SinusitisFAERS: 7US FAERS
203Supraventricular tachycardiaFAERS: 7US FAERS
204Transaminases increasedFAERS: 7US FAERS
205Urinary IncontinenceFAERS: 7US FAERS
206Urinary RetentionFAERS: 7US FAERS
207Accidental exposure to productFAERS: 6US FAERS
208Anaphylactoid ReactionFAERS: 6US FAERS
209AngioedemaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
210AphoniaFAERS: 6US FAERS
211Cerebral disorderFAERS: 6US FAERS
212CheilitisFAERS: 6US FAERS
213ConjunctivitisFAERS: 6US FAERS
214Delirium febrileFAERS: 6US FAERS
215Dry skinFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
216Duodenal UlcerFAERS: 6US FAERS
217DystoniaFAERS: 6US FAERS
218Electroencephalogram abnormalFAERS: 6US FAERS
219EntropionFAERS: 6US FAERS
220Eye irritationFAERS: 6US FAERS
221GastritisFAERS: 6US FAERS
222Incorrect drug administration durationFAERS: 6US FAERS
223Initial insomniaFAERS: 6US FAERS
224Limb discomfortFAERS: 6US FAERS
225Mental impairmentFAERS: 6US FAERS
226Panic DisorderFAERS: 6US FAERS
227Pharmaceutical product complaintFAERS: 6US FAERS
228Poor quality drug administeredFAERS: 6US FAERS
229Respiratory DepressionFAERS: 6US FAERS
230Respiratory distressFAERS: 6US FAERS
231SneezingFAERS: 6US FAERS
232Systemic Inflammatory Response SyndromeFAERS: 6US FAERS
233Therapy cessationFAERS: 6US FAERS
234ToothacheFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
235Urinary tract infectionFAERS: 6US FAERS
236Ventricular FibrillationFAERS: 6US FAERS
237nervous system disorderFAERS: 6US FAERS
238Accidental exposureFAERS: 5US FAERS
239ApathyFAERS: 5US FAERS
240Bipolar DisorderFAERS: 5US FAERS
241Bone painFAERS: 5US FAERS
242BronchitisFAERS: 5US FAERS
243ChokingFAERS: 5US FAERS
244Conversion disorderFAERS: 5US FAERS
245DementiaFAERS: 5US FAERS
246DysphemiaFAERS: 5US FAERS
247DysuriaFAERS: 5US FAERS
248Exposure via direct contactFAERS: 5US FAERS
249FibromyalgiaFAERS: 5US FAERS
250Gastric ulcerFAERS: 5US FAERS
251Gastrointestinal PainFAERS: 5US FAERS
252Guillain-Barre SyndromeFAERS: 5US FAERS
253Intentional product use issueFAERS: 5US FAERS
254Leukocytoclastic vasculitisFAERS: 5US FAERS
255LymphadenopathyFAERS: 5US FAERS
256Mouth swellingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
257MydriasisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Oculomucocutaneous syndromeFAERS: 5US FAERS
259Oral painFAERS: 5US FAERS
260Physical assaultFAERS: 5US FAERS
261PresyncopeFAERS: 5US FAERS
262PurpuraFAERS: 5US FAERS
263PyelonephritisFAERS: 5US FAERS
264Renal tubular necrosisFAERS: 5US FAERS
265Restless Legs SyndromeFAERS: 5US FAERS
266Skin reactionFAERS: 5US FAERS
267VasculitisFAERS: 5US FAERS
268Wrong drug administeredFAERS: 5US FAERS
269AnencephalyFAERS: 4US FAERS
270Angle Closure GlaucomaFAERS: 4US FAERS
271Brain ContusionFAERS: 4US FAERS
272Cerebral InfarctionFAERS: 4US FAERS
273Creatinine renal clearance decreasedFAERS: 4US FAERS
274CyanosisFAERS: 4US FAERS
275DroolingFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
276Ear discomfortFAERS: 4US FAERS
277Euphoric moodFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
278FormicationFAERS: 4US FAERS
279FractureFAERS: 4US FAERS
280Gait inabilityFAERS: 4US FAERS
281HemiplegiaFAERS: 4US FAERS
282HyperacusisFAERS: 4US FAERS
283IleusFAERS: 4US FAERS
284Impaired driving abilityFAERS: 4US FAERS
285Inappropriate affectFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
286Incorrect storage of drugFAERS: 4US FAERS
287Joint swellingFAERS: 4US FAERS
288LacerationFAERS: 4US FAERS
289Muscle RigidityFAERS: 4US FAERS
290Muscle SpasticityFAERS: 4US FAERS
291Neuroleptic Malignant SyndromeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
292Pain of skinFAERS: 4US FAERS
293PericarditisFAERS: 4US FAERS
294PhotophobiaFAERS: 4US FAERS
295Post-Traumatic Stress DisorderFAERS: 4US FAERS
296Product dispensing errorFAERS: 4US FAERS
297Pulmonary EmbolismFAERS: 4US FAERS
298Retinal DetachmentFAERS: 4US FAERS
299StressFAERS: 4US FAERS
300Therapy non-responderFAERS: 4US FAERS
301ThrombosisFAERS: 4US FAERS
302Violence-related symptomFAERS: 4US FAERS
303Viral mutation identifiedFAERS: 4US FAERS
304Activities of daily living impairedFAERS: 3US FAERS
305AnorexiaFAERS: 3US FAERS
306AnuriaFAERS: 3US FAERS
307Apparent deathFAERS: 3US FAERS
308AppendicitisFAERS: 3US FAERS
309Blood urea increasedFAERS: 3US FAERS
310Blood urine presentFAERS: 3US FAERS
311BradyphreniaFAERS: 3US FAERS
312BronchopneumoniaFAERS: 3US FAERS
313CatatoniaFAERS: 3US FAERS
314Choking sensationFAERS: 3US FAERS
315ChorioamnionitisFAERS: 3US FAERS
316ColitisFAERS: 3US FAERS
317Deep Vein ThrombosisFAERS: 3US FAERS
318EnuresisFAERS: 3US FAERS
319Erythema NodosumFAERS: 3US FAERS
320Excessive eye blinkingFAERS: 3US FAERS
321Exposure via breast milkFAERS: 3US FAERS
322Exposure via skin contactFAERS: 3US FAERS
323Eyelid Function DisorderFAERS: 3US FAERS
324Flat affectFAERS: 3US FAERS
325Food aversionFAERS: 3US FAERS
326Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
327Global AmnesiaFAERS: 3US FAERS
328Head discomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
329Hepatitis BFAERS: 3US FAERS
330HypothyroidismFAERS: 3US FAERS
331IncontinenceFAERS: 3US FAERS
332Incorrect product storageFAERS: 3US FAERS
333Intestinal ObstructionFAERS: 3US FAERS
334Lipase increasedFAERS: 3US FAERS
335MoaningFAERS: 3US FAERS
336Morbid thoughtsFAERS: 3US FAERS
337MyelitisFAERS: 3US FAERS
338MyositisFAERS: 3US FAERS
339Neck PainFAERS: 3US FAERS
340Negative thoughtsFAERS: 3US FAERS
341Neutrophil count decreasedFAERS: 3US FAERS
342No adverse effectFAERS: 3US FAERS
343NystagmusFAERS: 3US FAERS
344Obsessive-Compulsive DisorderFAERS: 3US FAERS
345Oral mucosal eruptionFAERS: 3US FAERS
346PetechiaeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
347PharyngitisFAERS: 3US FAERS
348PleurisyFAERS: 3US FAERS
349PoisoningFAERS: 3US FAERS
350PoriomaniaFAERS: 3US FAERS
351Product dose omissionFAERS: 3US FAERS
352Protein urine presentFAERS: 3US FAERS
353Pulmonary function test decreasedFAERS: 3US FAERS
354Renal painFAERS: 3US FAERS
355Respiratory tract congestionFAERS: 3US FAERS
356Scarlet FeverFAERS: 3US FAERS
357SchizophreniaFAERS: 3US FAERS
358Secretion dischargeFAERS: 3US FAERS
359Severe Acute Respiratory SyndromeFAERS: 3US FAERS
360Shoulder PainFAERS: 3US FAERS
361Sjogren's SyndromeFAERS: 3US FAERS
362Slow response to stimuliFAERS: 3US FAERS
363SplenomegalyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
364StridorFAERS: 3US FAERS
365TachyphreniaFAERS: 3US FAERS
366Thermal burnFAERS: 3US FAERS
367ThirstFAERS: 3US FAERS
368Thrombocytopenic purpuraFAERS: 3US FAERS
369TrismusFAERS: 3US FAERS
370UlcerFAERS: 3US FAERS
371Ventricular FlutterFAERS: 3US FAERS
372Viral myocarditisFAERS: 3US FAERS
373Waist circumference increasedFAERS: 3US FAERS
374Accidental deathFAERS: 2US FAERS
375AcneFAERS: 2US FAERS
376Acute psychosisFAERS: 2US FAERS
377AgranulocytosisFAERS: 2US FAERS
378AkathisiaFAERS: 2US FAERS
379Alice in Wonderland SyndromeFAERS: 2US FAERS
380Angina PectorisFAERS: 2US FAERS
381AnhedoniaFAERS: 2US FAERS
382AnophthalmosFAERS: 2US FAERS
383Aphthous StomatitisFAERS: 2US FAERS
384ArthritisFAERS: 2US FAERS
385AtaxiaFAERS: 2US FAERS
386Autoimmune hepatitisFAERS: 2US FAERS
387BedriddenFAERS: 2US FAERS
388BelligerenceFAERS: 2US FAERS
389Bilirubin conjugated increasedFAERS: 2US FAERS
390Blood amylase increasedFAERS: 2US FAERS
391Blood cholesterol increasedFAERS: 2US FAERS
392Blood creatinine abnormalFAERS: 2US FAERS
393Blood potassium decreasedFAERS: 2US FAERS
394Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
395Bowel movement irregularityFAERS: 2US FAERS
396BronchospasmFAERS: 2US FAERS
397BruxismFAERS: 2US FAERS
398Capsule physical issueFAERS: 2US FAERS
399Cardiac enzymes increasedFAERS: 2US FAERS
400CardiomegalyFAERS: 2US FAERS
401CellulitisFAERS: 2US FAERS
402CholecystitisFAERS: 2US FAERS
403ClumsinessFAERS: 2US FAERS
404Congenital HydrocephalusFAERS: 2US FAERS
405Congenital HypothyroidismFAERS: 2US FAERS
406Consciousness fluctuatingFAERS: 2US FAERS
407Decreased immune responsivenessFAERS: 2US FAERS
408Diabetes MellitusFAERS: 2US FAERS
409Diabetic KetoacidosisFAERS: 2US FAERS
410Drug toxicityFAERS: 2US FAERS
411DyscalculiaFAERS: 2US FAERS
412Educational problemFAERS: 2US FAERS
413Encephalitis influenzalFAERS: 2US FAERS
414EosinophiliaFAERS: 2US FAERS
415Eye inflammationFAERS: 2US FAERS
416Facial PainFAERS: 2US FAERS
417Facial paralysisFAERS: 2US FAERS
418Feeling of body temperature changeFAERS: 2US FAERS
419Flank PainFAERS: 2US FAERS
420Food AllergyFAERS: 2US FAERS
421GlomerulonephritisFAERS: 2US FAERS
422HungerFAERS: 2US FAERS
423HyperthyroidismFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
424HypogeusiaFAERS: 2US FAERS
425HypokinesiaFAERS: 2US FAERS
426Illogical thinkingFAERS: 2US FAERS
427Inappropriate schedule of product administrationFAERS: 2US FAERS
428Incorrect route of drug administrationFAERS: 2US FAERS
429Influenza A virus test positiveFAERS: 2US FAERS
430Influenza B virus test positiveFAERS: 2US FAERS
431Intercepted product preparation errorFAERS: 2US FAERS
432Irritable Bowel SyndromeFAERS: 2US FAERS
433Joint Range of Motion DecreasedFAERS: 2US FAERS
434Joint stiffnessFAERS: 2US FAERS
435LaryngitisFAERS: 2US FAERS
436Limb injuryFAERS: 2US FAERS
437Lip erosionFAERS: 2US FAERS
438Low birth weight babyFAERS: 2US FAERS
439MacrocephalyFAERS: 2US FAERS
440MacrocytosisFAERS: 2US FAERS
441MetamorphopsiaFAERS: 2US FAERS
442MonoparesisFAERS: 2US FAERS
443MoroseFAERS: 2US FAERS
444Multi-organ disorderFAERS: 2US FAERS
445Musculoskeletal chest painFAERS: 2US FAERS
446MutismFAERS: 2US FAERS
447NegativismFAERS: 2US FAERS
448Neonatal aspirationFAERS: 2US FAERS
449Neutropenic colitisFAERS: 2US FAERS
450Noninfective gingivitisFAERS: 2US FAERS
451Occupational exposure to productFAERS: 2US FAERS
452Ocular discomfortFAERS: 2US FAERS
453Ocular icterusFAERS: 2US FAERS
454OmphalitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
455Oropharyngeal blisteringFAERS: 2US FAERS
456Oropharyngeal discomfortFAERS: 2US FAERS
457Pericardial effusionFAERS: 2US FAERS
458PneumonitisFAERS: 2US FAERS
459PolymyositisFAERS: 2US FAERS
460Pre-EclampsiaFAERS: 2US FAERS
461Product complaintFAERS: 2US FAERS
462Product expiration date issueFAERS: 2US FAERS
463Product physical issueFAERS: 2US FAERS
464Product preparation errorFAERS: 2US FAERS
465Product tamperingFAERS: 2US FAERS
466Product use issueFAERS: 2US FAERS
467Retrograde amnesiaFAERS: 2US FAERS
468RosaceaFAERS: 2US FAERS
469Sinus headacheFAERS: 2US FAERS
470Skin irritationFAERS: 2US FAERS
471Skin lacerationFAERS: 2US FAERS
472Skin lesionFAERS: 2US FAERS
473SluggishnessFAERS: 2US FAERS
474Terminal stateFAERS: 2US FAERS
475Thrombosis in deviceFAERS: 2US FAERS
476Tongue blisteringFAERS: 2US FAERS
477Toxic Shock SyndromeFAERS: 2US FAERS
478Toxicity to various agentsFAERS: 2US FAERS
479Upper respiratory tract congestionFAERS: 2US FAERS
480UveitisFAERS: 2US FAERS
481Venous ThrombosisFAERS: 2US FAERS
482Venous thrombosis limbFAERS: 2US FAERS
483Vitreous floatersFAERS: 2US FAERS
484Wrong technique in product usage processFAERS: 2US FAERS
485furuncleFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
486muscle injuryFAERS: 2US FAERS
487Abdominal tendernessFAERS: 1US FAERS
488AcarodermatitisFAERS: 1US FAERS
489Accidental drug intake by childFAERS: 1US FAERS
490Accidental exposure to product by childFAERS: 1US FAERS
491Acne ConglobataFAERS: 1US FAERS
492Acute Lung InjuryFAERS: 1US FAERS
493Acute myocardial infarctionFAERS: 1US FAERS
494AkinesiaFAERS: 1US FAERS
495Alanine aminotransferase abnormalFAERS: 1US FAERS
496Alcohol poisoningFAERS: 1US FAERS
497Altered visual depth perceptionFAERS: 1US FAERS
498AmblyopiaFAERS: 1US FAERS
499AmimiaFAERS: 1US FAERS
500Amnestic DisorderFAERS: 1US FAERS
501AneurysmFAERS: 1US FAERS
502AnoxiaFAERS: 1US FAERS
503Apallic syndromeFAERS: 1US FAERS
504ArthropathyFAERS: 1US FAERS
505Aspartate aminotransferase abnormalFAERS: 1US FAERS
506AstigmatismFAERS: 1US FAERS
507AtelectasisFAERS: 1US FAERS
508Atrioventricular BlockFAERS: 1US FAERS
509Atypical pneumoniaFAERS: 1US FAERS
510Bacillus infectionFAERS: 1US FAERS
511BalanoposthitisFAERS: 1US FAERS
512Benign NeoplasmFAERS: 1US FAERS
513Bipolar I disorderFAERS: 1US FAERS
514Blighted ovumFAERS: 1US FAERS
515Blood albumin decreasedFAERS: 1US FAERS
516Blood alcohol increasedFAERS: 1US FAERS
517Blood bilirubin unconjugated increasedFAERS: 1US FAERS
518Blood creatine phosphokinase abnormalFAERS: 1US FAERS
519Blood electrolytes decreasedFAERS: 1US FAERS
520Blood glucose fluctuationFAERS: 1US FAERS
521Blood phosphorus increasedFAERS: 1US FAERS
522Blood potassium increasedFAERS: 1US FAERS
523Blood sodium decreasedFAERS: 1US FAERS
524Blood triglycerides increasedFAERS: 1US FAERS
525Bone marrow depressionFAERS: 1US FAERS
526BoredomFAERS: 1US FAERS
527Breast tendernessFAERS: 1US FAERS
528BronchiectasisFAERS: 1US FAERS
529Capsule issueFAERS: 1US FAERS
530Cardiac TamponadeFAERS: 1US FAERS
531Cardiac infectionFAERS: 1US FAERS
532CataractFAERS: 1US FAERS
533Central Nervous System InfectionFAERS: 1US FAERS
534Cerebellar AtaxiaFAERS: 1US FAERS
535ChromatopsiaFAERS: 1US FAERS
536ClaustrophobiaFAERS: 1US FAERS
537Coma scale abnormalFAERS: 1US FAERS
538Congenital pyelocaliectasisFAERS: 1US FAERS
539Counterfeit drug administeredFAERS: 1US FAERS
540Creatinine renal clearance increasedFAERS: 1US FAERS
541CystitisFAERS: 1US FAERS
542CystFAERS: 1US FAERS
543Cytokine Release SyndromeFAERS: 1US FAERS
544Cytolytic hepatitisFAERS: 1US FAERS
545Dandy-Walker SyndromeFAERS: 1US FAERS
546DermatitisFAERS: 1US FAERS
547Device ineffectiveFAERS: 1US FAERS
548Device malfunctionFAERS: 1US FAERS
549Diaphragmatic spasmFAERS: 1US FAERS
550DissociationFAERS: 1US FAERS
551DiverticulumFAERS: 1US FAERS
552Dose calculation errorFAERS: 1US FAERS
553Dreamy stateFAERS: 1US FAERS
554DrowningFAERS: 1US FAERS
555Drug abuseFAERS: 1US FAERS
556Drug administered to patient of inappropriate ageFAERS: 1US FAERS
557Drug dispensed to wrong patientFAERS: 1US FAERS
558Drug exposure before pregnancyFAERS: 1US FAERS
559Drug label confusionFAERS: 1US FAERS
560Drug level decreasedFAERS: 1US FAERS
561Drug therapy changedFAERS: 1US FAERS
562Duodenal ulcer perforationFAERS: 1US FAERS
563DwarfismFAERS: 1US FAERS
564Economic problemFAERS: 1US FAERS
565Ectopic PregnancyFAERS: 1US FAERS
566Endotoxic shockFAERS: 1US FAERS
567Endotracheal intubation complicationFAERS: 1US FAERS
568Eosinophilic PneumoniaFAERS: 1US FAERS
569Epigastric discomfortFAERS: 1US FAERS
570EpiglottitisFAERS: 1US FAERS
571Erectile dysfunctionFAERS: 1US FAERS
572Erythema InfectiosumFAERS: 1US FAERS
573Escherichia infectionFAERS: 1US FAERS
574Exaggerated startle responseFAERS: 1US FAERS
575Exposure via eye contactFAERS: 1US FAERS
576Eyelid painFAERS: 1US FAERS
577Facial asymmetryFAERS: 1US FAERS
578Feeding disorder neonatalFAERS: 1US FAERS
579Fight in schoolFAERS: 1US FAERS
580Foaming at mouthFAERS: 1US FAERS
581Forceps deliveryFAERS: 1US FAERS
582Foreign body traumaFAERS: 1US FAERS
583Frustration tolerance decreasedFAERS: 1US FAERS
584FrustrationFAERS: 1US FAERS
585Full blood count decreasedFAERS: 1US FAERS
586Gastric mucosal lesionFAERS: 1US FAERS
587Gastroduodenitis haemorrhagicFAERS: 1US FAERS
588Gastroenteritis norovirusFAERS: 1US FAERS
589Gastrointestinal infectionFAERS: 1US FAERS
590Gastrointestinal inflammationFAERS: 1US FAERS
591Gastrointestinal viral infectionFAERS: 1US FAERS
592Gaze palsyFAERS: 1US FAERS
593General symptomFAERS: 1US FAERS
594Genital burning sensationFAERS: 1US FAERS
595Genital dischargeFAERS: 1US FAERS
596Genital rashFAERS: 1US FAERS
597Gingival HypertrophyFAERS: 1US FAERS
598GlaucomaFAERS: 1US FAERS
599GliomaFAERS: 1US FAERS
600GliosisFAERS: 1US FAERS
601Gluten sensitivityFAERS: 1US FAERS
602Graft versus host disease in liverFAERS: 1US FAERS
603Granulocyte count decreasedFAERS: 1US FAERS
604Haptoglobin abnormalFAERS: 1US FAERS
605Head titubationFAERS: 1US FAERS
606HemiparesisFAERS: 1US FAERS
607Hepatic EncephalopathyFAERS: 1US FAERS
608Hepatitis AFAERS: 1US FAERS
609HepatomegalyFAERS: 1US FAERS
610HepatosplenomegalyFAERS: 1US FAERS
611HepatotoxicityFAERS: 1US FAERS
612HerniaFAERS: 1US FAERS
613HostilityFAERS: 1US FAERS
614HydrophobiaFAERS: 1US FAERS
615HyperchlorhydriaFAERS: 1US FAERS
616Hyperemesis GravidarumFAERS: 1US FAERS
617HyperreflexiaFAERS: 1US FAERS
618Hypoaesthesia facialFAERS: 1US FAERS
619ImmobileFAERS: 1US FAERS
620Immune thrombocytopenic purpuraFAERS: 1US FAERS
621ImmunosuppressionFAERS: 1US FAERS
622ImpatienceFAERS: 1US FAERS
623Inability to crawlFAERS: 1US FAERS
624Increased upper airway secretionFAERS: 1US FAERS
625Infectious MononucleosisFAERS: 1US FAERS
626Infectious pleural effusionFAERS: 1US FAERS
627Influenza virus test positiveFAERS: 1US FAERS
628Intercepted drug administration errorFAERS: 1US FAERS
629Intercepted drug dispensing errorFAERS: 1US FAERS
630Intercepted product administration errorFAERS: 1US FAERS
631Intercepted product prescribing errorFAERS: 1US FAERS
632Interleukin level increasedFAERS: 1US FAERS
633Intrauterine infectionFAERS: 1US FAERS
634IritisFAERS: 1US FAERS
635Irregular breathingFAERS: 1US FAERS
636KeratitisFAERS: 1US FAERS
637KetoacidosisFAERS: 1US FAERS
638Lichen PlanusFAERS: 1US FAERS
639Ligament painFAERS: 1US FAERS
640Limb massFAERS: 1US FAERS
641Lip exfoliationFAERS: 1US FAERS
642Livedo ReticularisFAERS: 1US FAERS
643Locked-In SyndromeFAERS: 1US FAERS
644Loss of personal independence in daily activitiesFAERS: 1US FAERS
645Lower respiratory tract infection viralFAERS: 1US FAERS
646Lower respiratory tract infectionFAERS: 1US FAERS
647Lung AbscessFAERS: 1US FAERS
648Lung consolidationFAERS: 1US FAERS
649LymphangitisFAERS: 1US FAERS
650Lymphocyte count abnormalFAERS: 1US FAERS
651Lymphocyte stimulation test positiveFAERS: 1US FAERS
652LymphopeniaFAERS: 1US FAERS
653Maternal exposure before pregnancyFAERS: 1US FAERS
654MeaslesFAERS: 1US FAERS
655Meconium ileusFAERS: 1US FAERS
656Meningeal disorderFAERS: 1US FAERS
657MeningismFAERS: 1US FAERS
658Metabolic acidosisFAERS: 1US FAERS
659MiliariaFAERS: 1US FAERS
660MonoplegiaFAERS: 1US FAERS
661Mucosal necrosisFAERS: 1US FAERS
662Muscle strainFAERS: 1US FAERS
663Musculoskeletal PainFAERS: 1US FAERS
664Mycobacterium test positiveFAERS: 1US FAERS
665Mycobacterium tuberculosis complex test positiveFAERS: 1US FAERS
666Myoglobin blood increasedFAERS: 1US FAERS
667MyopiaFAERS: 1US FAERS
668Neonatal disorderFAERS: 1US FAERS
669Neonatal respiratory acidosisFAERS: 1US FAERS
670Neonatal respiratory arrestFAERS: 1US FAERS
671NephrolithiasisFAERS: 1US FAERS
672NeuralgiaFAERS: 1US FAERS
673NeuroborreliosisFAERS: 1US FAERS
674Neurological examination abnormalFAERS: 1US FAERS
675Neuropsychiatric syndromeFAERS: 1US FAERS
676Non-cardiac chest painFAERS: 1US FAERS
677Noninfective encephalitisFAERS: 1US FAERS
678Nulli gravidaFAERS: 1US FAERS
679OligodipsiaFAERS: 1US FAERS
680Oral candidiasisFAERS: 1US FAERS
681Oral infectionFAERS: 1US FAERS
682Oral mucosal exfoliationFAERS: 1US FAERS
683Oropharyngeal plaqueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
684Oropharyngeal spasmFAERS: 1US FAERS
685Otitis ExternaFAERS: 1US FAERS
686Otitis MediaFAERS: 1US FAERS
687PCO2 increasedFAERS: 1US FAERS
688PO2 decreasedFAERS: 1US FAERS
689Paradoxical drug reactionFAERS: 1US FAERS
690Paranasal sinus hypersecretionFAERS: 1US FAERS
691ParaplegiaFAERS: 1US FAERS
692Peptic UlcerFAERS: 1US FAERS
693PertussisFAERS: 1US FAERS
694PhlebitisFAERS: 1US FAERS
695Physical disabilityFAERS: 1US FAERS
696Pierre Robin SyndromeFAERS: 1US FAERS
697PiloerectionFAERS: 1US FAERS
698Pituitary enlargementFAERS: 1US FAERS
699Platelet count abnormalFAERS: 1US FAERS
700Pneumococcal sepsisFAERS: 1US FAERS
701Post lumbar puncture syndromeFAERS: 1US FAERS
702Pregnancy of partnerFAERS: 1US FAERS
703PriapismFAERS: 1US FAERS
704Procedural hypotensionFAERS: 1US FAERS
705Product administration errorFAERS: 1US FAERS
706Product container issueFAERS: 1US FAERS
707Product contamination physicalFAERS: 1US FAERS
708Product counterfeitFAERS: 1US FAERS
709Product packaging issueFAERS: 1US FAERS
710Product physical consistency issueFAERS: 1US FAERS
711Product preparation issueFAERS: 1US FAERS
712Product use complaintFAERS: 1US FAERS
713ProteinuriaFAERS: 1US FAERS
714PseudomyopiaFAERS: 1US FAERS
715PsoriasisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
716Pulmonary FibrosisFAERS: 1US FAERS
717Pulmonary InfarctionFAERS: 1US FAERS
718Pulmonary congestionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
719PurulenceFAERS: 1US FAERS
720QuadriplegiaFAERS: 1US FAERS
721Quality of life decreasedFAERS: 1US FAERS
722Rash neonatalFAERS: 1US FAERS
723RegurgitationFAERS: 1US FAERS
724Renal ColicFAERS: 1US FAERS
725Retinopathy of PrematurityFAERS: 1US FAERS
726RhinalgiaFAERS: 1US FAERS
727RhinitisFAERS: 1US FAERS
728SacroiliitisFAERS: 1US FAERS
729ScabFAERS: 1US FAERS
730School refusalFAERS: 1US FAERS
731Seizure like phenomenaFAERS: 1US FAERS
732Similar reaction on previous exposure to drugFAERS: 1US FAERS
733Sinus ArrhythmiaFAERS: 1US FAERS
734Sinus TachycardiaFAERS: 1US FAERS
735Sinus bradycardiaFAERS: 1US FAERS
736Skin PapillomaFAERS: 1US FAERS
737Skin UlcerFAERS: 1US FAERS
738Skin hypertrophyFAERS: 1US FAERS
739Skin tightnessFAERS: 1US FAERS
740Somatoform disorder neurologicFAERS: 1US FAERS
741Sputum retentionFAERS: 1US FAERS
742Staphylococcal Scalded Skin SyndromeFAERS: 1US FAERS
743Staphylococcus test positiveFAERS: 1US FAERS
744Stress ulcerFAERS: 1US FAERS
745SubileusFAERS: 1US FAERS
746Sudden infant death syndromeFAERS: 1US FAERS
747Suicide threatFAERS: 1US FAERS
748SunburnFAERS: 1US FAERS
749Swelling of eyelidFAERS: 1US FAERS
750Symptom recurrenceFAERS: 1US FAERS
751Tardive DyskinesiaFAERS: 1US FAERS
752Temperature regulation disorderFAERS: 1US FAERS
753Tension HeadacheFAERS: 1US FAERS
754TetanyFAERS: 1US FAERS
755Therapeutic product ineffectiveFAERS: 1US FAERS
756Therapeutic response delayedFAERS: 1US FAERS
757Therapy changeFAERS: 1US FAERS
758Thirst decreasedFAERS: 1US FAERS
759Thyroid NeoplasmFAERS: 1US FAERS
760Tongue eruptionFAERS: 1US FAERS
761Tongue erythemaFAERS: 1US FAERS
762Tongue spasmFAERS: 1US FAERS
763Tonic clonic movementsFAERS: 1US FAERS
764Tooth LossFAERS: 1US FAERS
765ToxoplasmosisFAERS: 1US FAERS
766Traumatic renal injuryFAERS: 1US FAERS
767Treponema test positiveFAERS: 1US FAERS
768TrichiasisFAERS: 1US FAERS
769Trisomy 21FAERS: 1US FAERS
770Troponin increasedFAERS: 1US FAERS
771Tumour haemorrhageFAERS: 1US FAERS
772UnderweightFAERS: 1US FAERS
773Unevaluable investigationFAERS: 1US FAERS
774Upper-airway cough syndromeFAERS: 1US FAERS
775Urine albumin/creatinine ratio increasedFAERS: 1US FAERS
776Vasculitic rashFAERS: 1US FAERS
777Viral labyrinthitisFAERS: 1US FAERS
778Viral myositisFAERS: 1US FAERS
779Vitamin D DeficiencyFAERS: 1US FAERS
780Vitreous DetachmentFAERS: 1US FAERS
781Water IntoxicationFAERS: 1US FAERS
782Weaning failureFAERS: 1US FAERS
783Wound decompositionFAERS: 1US FAERS
784GlossitisCanada Vigilance: 1Canada Vigilance
785HypervigilanceCanada Vigilance: 1Canada Vigilance
786Jealous delusionCanada Vigilance: 1Canada Vigilance
787Mastication disorderCanada Vigilance: 1Canada Vigilance
788Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
789Pregnancy test positiveCanada Vigilance: 1Canada Vigilance
790Purulent dischargeCanada Vigilance: 1Canada Vigilance
791Tongue discomfortCanada Vigilance: 1Canada Vigilance
792Tongue exfoliationCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.